Skip to content

Cell Source, Inc.: 10-Q filed 2018-07-25

What Cell Source, Inc. reported in its quarterly report filed 2018-07-25 (fiscal Q3 2017): 21 published measures, 61 facts as tagged in accession 0001165527-18-000160.

This filing

Form
10-Q (quarterly report)
Filed
2018-07-25
Fiscal period
fiscal Q3 2017
Accession
0001165527-18-000160 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Cell Source, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2017-09-30150,114USD
At 2016-12-31211,103USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2017-09-30-5,564,352USD
At 2016-12-31-6,242,949USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2017-09-3040,203USD
At 2016-12-313,735USD
At 2016-09-301,638USD
At 2015-12-316,944USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-07-01 to 2017-09-30-508,545USD92
2017-01-01 to 2017-09-30-2,473,362USD273
2016-07-01 to 2016-09-30-803,352USD92
2016-01-01 to 2016-09-30-2,324,580USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2017-09-30-13,943,739USD
At 2016-12-31-11,470,377USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2016-12-31407USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2017-07-01 to 2017-09-30351USD92
2017-01-01 to 2017-09-3044,634USD273
2016-07-01 to 2016-09-3023,627USD92
2016-01-01 to 2016-09-30115,589USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2017-07-01 to 2017-09-30-555,138USD92
2017-01-01 to 2017-09-30-1,685,358USD273
2016-07-01 to 2016-09-30-601,737USD92
2016-01-01 to 2016-09-30-1,776,582USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2017-09-30150,114USD
At 2016-12-31210,696USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2017-07-01 to 2017-09-3033,445USD92
2017-01-01 to 2017-09-30144,112USD273
2016-07-01 to 2016-09-3061,513USD92
2016-01-01 to 2016-09-30178,582USD274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2017-09-305,714,466USD
At 2016-12-316,454,052USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2017-09-30254,431USD
At 2016-12-31219,094USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2017-07-01 to 2017-09-30555,138USD92
2017-01-01 to 2017-09-301,685,358USD273
2016-07-01 to 2016-09-30601,737USD92
2016-01-01 to 2016-09-301,776,582USD274

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2017-07-01 to 2017-09-30202,480USD92
2017-01-01 to 2017-09-30662,455USD273
2016-07-01 to 2016-09-30261,914USD92
2016-01-01 to 2016-09-30814,351USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2017-07-01 to 2017-09-30152,658USD92
2017-01-01 to 2017-09-30422,903USD273
2016-07-01 to 2016-09-30133,866USD92
2016-01-01 to 2016-09-30357,454USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2017-09-3024,773,006shares
At 2016-12-3124,679,256shares

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2017-09-30888,719USD
At 2016-12-31875,212USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2017-07-01 to 2017-09-30-582,806USD92
2017-01-01 to 2017-09-30-2,623,992USD273
2016-07-01 to 2016-09-30-803,352USD92
2016-01-01 to 2016-09-30-2,324,580USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2017-01-01 to 2017-09-30407USD273
2016-01-01 to 2016-09-30645USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2017-07-01 to 2017-09-3046,593USD92
2017-01-01 to 2017-09-30-788,004USD273
2016-07-01 to 2016-09-30-201,615USD92
2016-01-01 to 2016-09-30-547,998USD274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-09-3035,337USD273
2016-01-01 to 2016-09-3089,708USD274

Inspect the source

Entity
Cell Source, Inc. / CIK 0001569340
Captured
2026-09-20T09:20:59.488Z
SEC response SHA-256
a38ee9440e4c17d7e1a60b5c62fea787c32a17056a875641a758e857a5dd95d2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001569340.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))